Geneos Wealth Management Inc. Purchases 3,149 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Geneos Wealth Management Inc. boosted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 95.2% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 6,458 shares of the company's stock after buying an additional 3,149 shares during the period. Geneos Wealth Management Inc.'s holdings in HCA Healthcare were worth $2,232,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Atwood & Palmer Inc. bought a new stake in shares of HCA Healthcare in the 1st quarter valued at approximately $28,000. Bartlett & CO. Wealth Management LLC grew its stake in shares of HCA Healthcare by 888.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock valued at $31,000 after buying an additional 80 shares in the last quarter. ORG Partners LLC grew its stake in shares of HCA Healthcare by 344.0% in the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock valued at $38,000 after buying an additional 86 shares in the last quarter. Migdal Insurance & Financial Holdings Ltd. grew its stake in shares of HCA Healthcare by 75.8% in the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock valued at $40,000 after buying an additional 50 shares in the last quarter. Finally, Legacy Investment Solutions LLC boosted its position in HCA Healthcare by 99.0% during the fourth quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock worth $62,000 after purchasing an additional 95 shares during the period. Institutional investors and hedge funds own 62.73% of the company's stock.

Insider Buying and Selling at HCA Healthcare

In other news, COO Jon M. Foster sold 15,698 shares of the firm's stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the sale, the chief operating officer directly owned 12,646 shares in the company, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Company insiders own 1.30% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the company. Truist Financial upped their target price on HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a research report on Wednesday, July 16th. Morgan Stanley decreased their target price on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a research report on Monday. Royal Bank Of Canada set a $401.00 target price on HCA Healthcare and gave the stock an "outperform" rating in a research report on Monday. Robert W. Baird reissued a "neutral" rating and issued a $336.00 price objective (down from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Finally, Baird R W cut HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Nine investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $396.46.

HCA Healthcare Stock Performance

HCA stock traded up $2.85 during midday trading on Friday, hitting $356.84. The stock had a trading volume of 1,369,756 shares, compared to its average volume of 1,559,973. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07. The stock has a 50-day simple moving average of $371.06 and a 200 day simple moving average of $346.78. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The firm has a market capitalization of $85.84 billion, a price-to-earnings ratio of 15.00, a P/E/G ratio of 1.11 and a beta of 1.39.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%. The firm had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. During the same period in the prior year, the company posted $5.50 earnings per share. The business's revenue for the quarter was up 6.4% compared to the same quarter last year. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be paid a $0.72 dividend. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare's dividend payout ratio (DPR) is 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.